Search

Your search keyword '"Canakinumab -- Reports -- Forecasts and trends"' showing total 17 results
Start Over Descriptor "Canakinumab -- Reports -- Forecasts and trends"
17 results on '"Canakinumab -- Reports -- Forecasts and trends"'

1. Alcoholic Hepatitis Market Insights, Epidemiology and Market Forecasts to 2030

Subjects
DURECT Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Hepatitis -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. The [...]

Published
2020

2. Alcoholic Hepatitis Market Insights, Epidemiology and Market Forecasts to 2030 - ResearchAndMarkets.com

Subjects
DURECT Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Hepatitis -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. The Alcoholic Hepatitis market report provides analysis regarding current [...]

Published
2020

3. Global Alcoholic Hepatitis Market: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

Subjects
DURECT Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Drugs -- Reports -- Forecasts and trends, Hepatitis -- Drug therapy, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - The 'Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. The Alcoholic Hepatitis market report provides analysis regarding current [...]

Published
2020

4. Global Alcoholic Hepatitis Market: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

Subjects
DURECT Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Drugs -- Reports -- Forecasts and trends, Hepatitis -- Drug therapy, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, international, Law
Abstract

(GlobeNewswire) - The 'Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. The Alcoholic Hepatitis market report provides analysis regarding current [...]

Published
2020

5. Alcoholic Hepatitis Market Insights, Epidemiology and Market Forecasts to 2030

Subjects
DURECT Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Hepatitis -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-December 10, 2020-: Alcoholic Hepatitis Market Insights, Epidemiology and Market Forecasts to 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:10122020 The 'Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast - 2030' drug [...]

Published
2020

6. Cytokine Release Syndrome Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

Subjects
Business research -- Reports -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Cytokines -- Reports -- Forecasts and trends, Drugs -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Anakinra -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-August 21, 2020-: Cytokine Release Syndrome Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight (C)1994-2020 M2 COMMUNICATIONS RDATE:21082020 (Albany, US) DelveInsight launched a new [...]

Published
2020

7. Acute Gout Flare Market, Size, Share, Trends, Epidemiology Forecast till 2030

Subjects
Canakinumab -- Reports -- Forecasts and trends, Gout -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-August 18, 2020-: Acute Gout Flare Market, Size, Share, Trends, Epidemiology Forecast till 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:17082020 DelveInsight's 'Acute gout Flare Market Insights, Epidemiology, and Market Forecast-2030' report [...]

Published
2020

8. Worldwide COVID-19 Diagnostics and Therapy Industry to 2025 - Agreements, Deals, Partnerships, Collaborations & Joint Ventures

Subjects
Vaccines -- Forecasts and trends -- Reports, Canakinumab -- Reports -- Forecasts and trends, Antiviral agents -- Forecasts and trends -- Reports, Immunotherapy -- Reports -- Forecasts and trends, Joint ventures -- Forecasts and trends -- Reports, Siltuximab -- Forecasts and trends -- Reports, COVID-19 -- Reports -- Forecasts and trends, Partnerships -- Reports -- Forecasts and trends, Company joint venture, Market trend/market analysis, Business, international, Law
Abstract

(GlobeNewswire) - The 'COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025' report has been added to [...]

Published
2020

9. Worldwide COVID-19 Diagnostics and Therapy Industry to 2025 - Agreements, Deals, Partnerships, Collaborations & Joint Ventures

Subjects
Vaccines -- Forecasts and trends -- Reports, Canakinumab -- Reports -- Forecasts and trends, Antiviral agents -- Forecasts and trends -- Reports, Immunotherapy -- Reports -- Forecasts and trends, Joint ventures -- Forecasts and trends -- Reports, Siltuximab -- Forecasts and trends -- Reports, COVID-19 -- Reports -- Forecasts and trends, Partnerships -- Reports -- Forecasts and trends, Company joint venture, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, July 21, Jul 21, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and [...]

Published
2020

10. Global COVID-19 Diagnostics and Therapy Market (2020 to 2025) - Featuring Medicago, Moderna & Novavax Among Others

Subjects
Vaccines -- Forecasts and trends -- Reports, Canakinumab -- Reports -- Forecasts and trends, Antiviral agents -- Forecasts and trends -- Reports, Immunotherapy -- Reports -- Forecasts and trends, Siltuximab -- Forecasts and trends -- Reports, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global [...]

Published
2020

11. Cytokine Release Syndrome Market, Size, Share, Trends, Epidemiology Forecast till 2030

Subjects
Canakinumab -- Reports -- Forecasts and trends, Cytokines -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Anakinra -- Reports -- Forecasts and trends, T cells -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 21, 2020-: Cytokine Release Syndrome Market, Size, Share, Trends, Epidemiology Forecast till 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:20072020 DelveInsight's 'Cytokine Release Syndrome Market Insights, Epidemiology, and Market Forecast-2030' report [...]

Published
2020

12. Global COVID-19 Diagnostics and Therapy Market (2020 to 2025) - Featuring Medicago, Moderna & Novavax Among Others - ResearchAndMarkets.com

Subjects
Vaccines -- Forecasts and trends -- Reports, Canakinumab -- Reports -- Forecasts and trends, Antiviral agents -- Forecasts and trends -- Reports, Immunotherapy -- Reports -- Forecasts and trends, Siltuximab -- Forecasts and trends -- Reports, COVID-19 -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025' report has been added to [...]

Published
2020

13. Global COVID-19 Diagnostics and Therapy Market (2020 to 2025) - Featuring Medicago, Moderna & Novavax Among Others

Subjects
Vaccines -- Forecasts and trends -- Reports, Canakinumab -- Reports -- Forecasts and trends, Antiviral agents -- Forecasts and trends -- Reports, Immunotherapy -- Reports -- Forecasts and trends, Siltuximab -- Forecasts and trends -- Reports, COVID-19 -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 17, 2020-: Global COVID-19 Diagnostics and Therapy Market (2020 to 2025) - Featuring Medicago, Moderna & Novavax Among Others (C)1994-2020 M2 COMMUNICATIONS RDATE:17072020 The 'COVID-19 Diagnostics (PCR Testing, [...]

Published
2020

14. Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030

Subjects
Cabozantinib -- Reports -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, German foreign relations, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - [...]

Published
2020

15. Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030 - ResearchAndMarkets.com

Subjects
Cabozantinib -- Reports -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, German foreign relations, Lung cancer, Profits, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's [...]

Published
2020

16. Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030

Subjects
Cabozantinib -- Reports -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, German foreign relations, Lung cancer, Profits, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 4, 2020-: Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:04062020 The 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) [...]

Published
2020

17. Programmed Death-Ligand 1 PD-L1 Non-Small Cell Lung Cancer NSCLC Market Insights and Forecasts, 2017-2030 - ResearchAndMarkets.com

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, Canakinumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Avelumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Cemiplimab -- Forecasts and trends -- Reports, Market trend/market analysis, Health
Abstract

2020 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results